Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$22.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 20 most recent Form 4 transactions.
| Sep 30, 2025 | LENZ | LENZ Therapeutics, Inc. | SSELL | 57,502 | $46.41 | $2.7M | -7.0% | Open the original filing on SEC.gov |
| Sep 30, 2025 | LENZ | LENZ Therapeutics, Inc. | SSELL | 83,066 | $46.41 | $3.9M | -7.3% | Open the original filing on SEC.gov |
| Sep 30, 2025 | LENZ | LENZ Therapeutics, Inc. | SSELL | 34,405 | $45.35 | $1.6M | -4.0% | Open the original filing on SEC.gov |
| Sep 30, 2025 | LENZ | LENZ Therapeutics, Inc. | SSELL | 49,701 | $45.35 | $2.3M | -4.2% | Open the original filing on SEC.gov |
| Sep 19, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 532,870 | $1.40 | $746.8K | -100.0% | Open the original filing on SEC.gov |
| Sep 19, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 2.4M | $1.40 | $3.3M | -100.0% | Open the original filing on SEC.gov |
| Sep 18, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 228,791 | $1.44 | $329.9K | -30.0% | Open the original filing on SEC.gov |
| Sep 18, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 366,111 | $1.44 | $527.9K | -13.4% | Open the original filing on SEC.gov |
| Sep 18, 2025 | LENZ | LENZ Therapeutics, Inc. | SSELL | 132 | $43.30 | $5.7K | <0.1% | Open the original filing on SEC.gov |
| Sep 18, 2025 | LENZ | LENZ Therapeutics, Inc. | SSELL | 268 | $43.30 | $11.6K | <0.1% | Open the original filing on SEC.gov |
| Sep 18, 2025 | LENZ | LENZ Therapeutics, Inc. | SSELL | 20,148 | $43.00 | $866.4K | -2.3% | Open the original filing on SEC.gov |
| Sep 18, 2025 | LENZ | LENZ Therapeutics, Inc. | SSELL | 40,907 | $43.00 | $1.8M | -3.3% | Open the original filing on SEC.gov |
| Sep 18, 2025 | LENZ | LENZ Therapeutics, Inc. | SSELL | 24,370 | $41.59 | $1M | -2.7% | Open the original filing on SEC.gov |
| Sep 18, 2025 | LENZ | LENZ Therapeutics, Inc. | SSELL | 49,479 | $41.59 | $2.1M | -3.9% | Open the original filing on SEC.gov |
| Sep 17, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 226,726 | $1.49 | $337.6K | -22.9% | Open the original filing on SEC.gov |
| Sep 17, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 362,806 | $1.49 | $540.3K | -11.7% | Open the original filing on SEC.gov |
| Sep 16, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 192,293 | $1.53 | $294.8K | -16.3% | Open the original filing on SEC.gov |
| Sep 16, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 307,707 | $1.53 | $471.8K | -9.0% | Open the original filing on SEC.gov |